Seroprevalence of pertussis antitoxin (anti-PT) in Sweden before and 10 years after the introduction of a universal childhood pertussis vaccination program

APMIS

Volumn 117, Issue 12, 2009, Pages 912-922

  Hallander, Hans O ^a   Andersson, Mikael ^a   Gustafsson, Lennart ^a   Ljungman, Margaretha ^a   Netterlid, Eva ^a  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

ELISA IgG anti PT; Pertussis; Seroepidemiology; Sweden

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; PERTUSSIS TOXIN; PERTUSSIS VACCINE;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BORDETELLA PERTUSSIS; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GROUPS BY AGE; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; PERTUSSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; SEROPREVALENCE; SWEDEN; UMBILICAL CORD BLOOD; VACCINATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; BORDETELLA PERTUSSIS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MIDDLE AGED; PERTUSSIS TOXIN; PERTUSSIS VACCINE; SEROEPIDEMIOLOGIC STUDIES; SWEDEN; VACCINATION; WHOOPING COUGH; YOUNG ADULT;

EID: 70450196765     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2009.02554.x     Document Type: Article

References (28)

1. Carlsson RM, Gustafsson L. Ten year report. Pertussis surveillance in Sweden. Progress report October 1, 1997-December 31, 2007. Solna, Sweden : Smittskyddsinstitutet : 2008 Report No 4.
2. Cattaneo LA, Reed GW, Haase DH, Wills MJ, Edwards KM. The seroepidemiology of Bordetella pertussis infections: a study of persons ages 1-65 years. J Infect Dis 1996 173 : 1256 1259.
3. Celentano LP, Massari M, Paramatti D, Salmaso S, Tozzi AE. Resurgence of Pertussis in Europe. Pediatr Infect Dis J 2005 24 : 761 765.
4. Crowcroft NS, Booy R, Harrison T, Spicer L, Britto J, Mok Q, et al. Severe and unrecognised: pertussis in UK infants. Arch Dis Child 2003 88 : 802 806.
5. von Konig CH, Halperin S, Riffelmann M, Guiso N. Pertussis of adults and infants. Lancet Infect Dis 2002 2 : 744 750.
6. Forsyth K. Pertussis, still a formidable foe. Clin Infect Dis 2007 45 : 1487 1491.
7. Forsyth KD, Wirsing von Konig CH, Tan T, Caro J, Plotkin S. Prevention of pertussis: recommendations derived from the second Global Pertussis Initiative roundtable meeting. Vaccine 2007 25 : 2634 2642.
8. Heininger U. Pertussis: an old disease that is still with us. Curr Opin Infect Dis 2001 14 : 329 335.
9. Cherry JD. Epidemiology of pertussis. Pediatr Infect Dis J 2006 25 : 361 362.
10. Preziosi MP, Halloran ME. Effects of pertussis vaccination on transmission: vaccine efficacy for infectiousness. Vaccine 2003 21 : 1853 1861.
11. Trollfors B, Taranger J, Lagergard T, Sundh V, Bryla DA, Schneerson R, et al. Immunization of children with pertussis toxoid decreases spread of pertussis within the family. Pediatr Infect Dis J 1998 17 : 196 199.
12. Mossong J, Putz L, Shkedy Z, Schneider F. Seroepidemiology of diphtheria and pertussis in Luxembourg in 2000. Epidemiol Infect 2006 134 : 573 578.
13. Pavlopoulou ID, Syriopoulou V, Daikos GL, Fourlani H, Tzivaras A, Petychakis D, et al. Pertussis seroprevalence in different age groups in Greece. Scand J Infect Dis 2007 39 : 14 8.
14. Pebody RG, Gay NJ, Giammanco A, Baron S, Schellekens J, Tischer A, et al. The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiol Infect 2005 133 : 159 171.
15. Storsaeter J, Hallander HO, Gustafsson L, Olin P. Low levels of antipertussis antibodies plus lack of history of pertussis correlate with susceptibility after household exposure to Bordetella pertussis. Vaccine 2003 21 : 3542 3549.
16. Olin P, Carlsson RM, Johansen K, Hallander HO, Ljungman M, Svensson Å, et al. Vaccinationsuppföljning, Seroepidemiologisk tvärsnittsstudie 1997. Slutrapport : SMI:s rapportserie, 2004.
17. Hallander HO, Gustafsson L, Ljungman M, Storsaeter J. Pertussis antitoxin decay after vaccination with DTPa: Response to a first booster dose - years after the third vaccine dose. Vaccine 2005 23 : 5359 5364.
18. Hallander HO, Ljungman M, Storsaeter J, Gustafsson L. Kinetics and sensitivity of ELISA IgG pertussis antitoxin after infection and vaccination with Bordetella pertussis in young children. APMIS 2009 117 : 797 807.
19. Gustafsson L, Hessel L, Storsaeter J, Olin P. Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age. Pediatrics 2006 118 : 978 984.
20. Hallander HO. Microbiological and serological diagnosis of pertussis. Clin Infect Dis 1999 28 (Suppl. 2 S99 106.
21. Reizenstein E, Hallander HO, Blackwelder WC, Kuhn I, Ljungman M, Mollby R. Comparison of five calculation modes for antibody ELISA procedures using pertussis serology as a model. J Immunol Methods 1995 183 : 279 290.
22. Gustafsson L, Hallander HO, Olin P, Reizenstein E, Storsaeter J. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med 1996 334 : 349 355.
23. Giammanco A, Chiarini A, Maple PA, Andrews N, Pebody R, Gay N, et al. European Sero-Epidemiology Network: standardisation of the assay results for pertussis. Vaccine 2003 22 : 112 120.
24. Healy CM, Munoz FM, Rench MA, Halasa NB, Edwards KM, Baker CJ. Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum. J Infect Dis 2004 190 : 335 340.
25. Nardone A, Pebody RG, Maple PA, Andrews N, Gay NJ, Miller E. Sero-epidemiology of Bordetella pertussis in England and Wales. Vaccine 2004 22 : 1314 1319.
26. Wright SW, Decker MD, Edwards KM. Incidence of pertussis infection in healthcare workers. Infect Control Hosp Epidemiol 1999 20 : 120 123.
27. de Melker HE, Versteegh FG, Schellekens JF, Teunis PF, Kretzschmar M. The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys. J. Infect. 2006 53 : 106 113.
28. Rohani P, Earn DJ, Grenfell BT. Impact of immunisation on pertussis transmission in England and Wales. Lancet 2000 355 : 285 286. (Pubitemid 30068523)